ArticleBone marrow transplantation2014

Allogeneic hematopoietic cell transplantation for myelofibrosis in patients pretreated with the JAK1 and JAK2 inhibitor ruxolitinib.

N Jaekel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.